Sat, May 27, 2017 | updated 01:40 PM IST

6-months clinical trial data finds Indian thin strut fully dissolvable stent to be safe

Updated: Nov 02, 2016 10:34 IST      
6-months clinical trial data finds Indian thin strut fully dissolvable stent to be safe

New Delhi [India], Nov2 (ANI): Findings of the six month clinical trial on the first thin strut fully dissolvable stent in the world, developed in India, were unveiled at the prestigious main arena, Late Breaking Clinical Trials/First Report Investigations at the Cardiovascular Therapeutics (TCT) 2016, Washington DC on October 31.

The TCT is the biggest and best regarded meeting of interventional cardiologists in the world. This was a proud moment for India, as the data was presented by the eminent interventional cardiologist Dr Ashok Seth, Chairman Fortis Escorts Heart Institute, who was the principal investigator of the study.

The study titled MeRes-1 is the first-in-man study of the novel thin-strut PLLA-based sirolimus-eluting bioresorbable vascular stent (MeRes100). It considered Six-Month Clinical, Angiographic, Intravascular ultrasound (IVUS), and Optical coherence tomography (OCT) results in patients with Coronary Artery Disease.

Presenting the findings of the study, Dr. Seth said, "This is a big day for India and the 'Make in India' program. It also reveals to the world that our Indian device industry has the ability to be innovative, creative and support high quality research. The innovative design of the MeRes100 scaffold developed in India addresses some of the limitations of currently available Bio Resorbable Stents (dissolvable stents) and may have higher success and lower complication rates in the long term. It would also cost much lesser than the currently available dissolvable stents and therefore give more benefit to higher number of patients. The MeRes-1, first-in-man study demonstrates that this new generation thinner strut sirolimus eluting BRS is both safe and effective at six months. These encouraging results provide the basis for further studies using wider range of length and sizes in more complex and larger patient population."

The MeRes100 is a low profile 100µm thin strut PLLA based BRS with a unique hybrid design featuring open cells at the center and closed cells at the edges resulting in improved track-ability and access to side branches. It also has enhanced visibility with three circumferential radio opaque markers at each end.

In this prospective, multicenter, single arm trial of MeRes100 BRS, a total of 108 patients (116 lesions) were enrolled at 16 Indian sites from May 2015 to April 2016.

The primary end-point was Major Adverse Cardiac Events (MACE), a composite of cardiac death, myocardial infarction, Ischaemia Driven Target Lesion Revascularization (ID-TLR), and Ischaemia Driven Target Vessel Revascularization (ID-TVR) at six months. The secondary end-point was scaffold thrombosis at six months.

The study found no MACE or stent thrombosis (ST) after the deployment of the scaffold up to six month follow-up.

Quantitative Coronary Analysis (QCA) data at six months demonstrated very favourable in scaffold late lumen loss of 0.15±0.26mm. Intravascular ultrasound (IVUS) and Optical coherence tomography (OCT) analysis showed no scaffold recoil and near complete strut coverage (99.3percent) with neointima.

The TCT is the annual scientific symposium of the Cardiovascular Research Foundation (CRF) featuring a number of first report investigations on novel stents that could become the next generation of bioresorbable stents in patients.

"Bioresorbable stents (dissolvable stents) have the potential to be greatly impactful in the treatment of coronary artery disease, and it is exciting to see these first report investigations of several new and novel stents advancing the technology forward," said Ajay Kirtane, , a Co-Director of TCT.

"These results give us the first insights into their safety and efficacy, but larger randomized trials are necessary in order to establish their role in clinical practice," he added. (ANI)

New hope for stroke patients with disabilities

Updated: May 27, 2017 11:22 IST     

Washington D.C.[USA], May 27 (ANI): Stroke patients left with disabilities have been offered new hope as scientists have developed mind-controlled device that helps them retrain brains to move paralyzed hands.

Full Story >>

Washington D.C. [USA], May 27 (ANI): According to a new study, people suffering from HIV tend to spend more time in therapy to manage the chronic condition.

Full Story >>

New Delhi [India], May 26 (ANI): Latest robotic surgery may work as a boon for patients suffering from early stage oropharyngeal carcinoma (cancer of the mouth, neck and throat).

Full Story >>

23-year-old suffers severe heart attack due to smoking

Updated: May 26, 2017 16:01 IST     

New Delhi [India], May 26 (ANI): With several reasons attributing to a paradigm shift in the age groups suffering from heart attacks to younger age brackets, tobacco induced cardiac arrests rate as one of the topmost ones.

Full Story >>

New Delhi [India], May 26 (ANI): According to statistics, India has the third largest Muslim population in the world. The month of Ramadan is about to begin and a vast majority of this population will be fasting for a large number of days.

Full Story >>

Frequent recreational weed puts your mouth at risk

Updated: May 26, 2017 08:12 IST     

Washington D.C. [USA], May 26 (ANI): Frequent recreational use of cannabis, including marijuana, hashish, and hash oil, ups the risk of gum disease, a recent study has found.

Full Story >>

Washington D.C. [USA], May 25 (ANI): A study, presented at EuroCMR, says that chemotherapy-induced cardiomyopathy react more on men than women.

Full Story >>

New Delhi [India], May 25 (ANI): Envisioning a leap in emergency care, Aster DM Healthcare on Thursday launched its most novel and unique concept, the 'Aster Emergency' app, which will offer real-time interface between the patient in emergency and a GPS-enabled Aster 'Responder'.

Full Story >>

New Delhi [India], May 25 (ANI-BusinessWireIndia): Everyuth Naturals, a pioneer and a leading skincare brand known for its natural ingredients and effective products has announced the re-launch of its flagship product in the face wash category with-the new improved Everyuth Tulsi Turmeric Face Wash.

Full Story >>

New Delhi [India], May 25 (ANI): A Sutureless Valve Replacement surgery was recently performed on a 78 year old patient by Global Hospitals, Mumbai.

Full Story >>

Suicide rates among people with autism on rise

Updated: May 25, 2017 11:26 IST     

Washington D.C. [USA], May 25 (ANI): According to a recent study, suicide rates among autism patients have reached 'worryingly' high levels.

Full Story >>

Unhappy, less aware youth prone to alcohol addiction

Updated: May 25, 2017 10:36 IST     

Washington D.C. [USA], May 25 (ANI): Making youth aware of the harms of smoking and drinking could help them steer away from alcohol and cigarettes, suggests a recent study.

Full Story >>

London [UK], May 24 (ANI): Sleep is the easiest thing to forego by hardworking individuals. What we don't realize is, when sleep fails, one's health declines along with the quality of life.

Full Story >>

Washington D.C. [USA], May 24 (ANI): According to a recent study, adequate levels of Vitamin D combined with good sleep can help you manage chronic arthritis and back pain.

Full Story >>

Washington D.C. [USA], May 24 (ANI): You might consider yourself to be a recreational user but could be further along the road to drug addiction than you might have realized, a study suggests.

Full Story >>

Washington D.C. [USA], May 24 (ANI): A recent study shows a multi-protein biomarker blood test to detect breast cancer can potentially reduce use of biopsy up to 67percent.

Full Story >>

Childhood obesity results in early onset of arthritis

Updated: May 24, 2017 09:32 IST     

New Delhi [India], May 7 (ANI): Obesity, which is assuming epidemic proportions among children, is proving too much on their delicate bones and joints.

Full Story >>

Washington D.C. [USA], May 24 (ANI): A team of researchers has found that intestinal fungi, chronic liver damage, increase risk of death for the people with alcohol-related liver disease.

Full Story >>

Here's what dentists can tell about your health

Updated: May 23, 2017 16:46 IST     

Washington D.C. [USA], May 23 (ANI): A recent study has found that by using medical and dental records, researchers can identify what is the cause of disease and how the patients with certain diseases will respond to surgery, medication or other interventions.

Full Story >>

Trying to lose weight? Dieting may not help

Updated: May 23, 2017 15:08 IST     

Washington D.C. [USA], May 23 (ANI): Dieting has a little effect on losing weight, as a study finds that brain cells act as a trigger to prevent us burning calories when food is scarce.

Full Story >>